Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 9, 2008 - Issue 9
Submit an article Journal homepage
32
Views
5
CrossRef citations to date
0
Altmetric
Editorial

Primary and secondary coronary heart disease prevention using statins: is targeting Adam or Eve equally effective?

Anna I Kakafika Aristotle University of Thessaloniki, Hippokration Hospital, Medical School, Second Propedeutic Department of Internal Medicine, Thessaloniki, Greece
,
Vasilios G Athyros Aristotle University of Thessaloniki, Hippokration Hospital, Medical School, Second Propedeutic Department of Internal Medicine, Thessaloniki, Greece
,
Konstantinos Tziomalos University College London, Royal Free Hospital campus, Department of Clinical Biochemistry (Vascular Prevention Clinic), Pond Street, London, UK +44 020 7830 2258; +44 020 7830 2235; [email protected]
,
Asterios Karagiannis Aristotle University of Thessaloniki, Hippokration Hospital, Medical School, Second Propedeutic Department of Internal Medicine, Thessaloniki, Greece
&
Dimitri P Mikhailidis University College London, Royal Free Hospital campus, Department of Clinical Biochemistry (Vascular Prevention Clinic), Pond Street, London, UK +44 020 7830 2258; +44 020 7830 2235; [email protected]
, MD FFPM FRCP FRCPath
Pages 1437-1440 | Published online: 02 Jun 2008

Bibliography

  • Jacobs D, Blackburn H, Higgins M, et al. Report of the conference on low blood cholesterol: mortality associations. Circulation 1992;86:1046-60
  • Walsh JM, Pignone M. Drug treatment of hyperlipidemia in women. JAMA 2004;291:2243-52
  • Larosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA 1999;282:2340-6
  • Ulmer H, Kelleher C, Diem G, et al. Why Eve is not Adam: prospective follow-up in 149,650 women and men of cholesterol and other risk factors related to cardiovascular and all-cause mortality. J Womens Health 2004;13:41-53
  • Ford ES, Capewell S. Coronary heart disease mortality among young adults in the US from 1980 through 2002. Concealed leveling of mortality rates. J Am Coll Cardiol 2007;50:2128-32
  • Greenland P, Lloyd-Jones D. Time to end the mixed – and often incorrect – messages about prevention and treatment of atherosclerotic cardiovascular disease. J Am Coll Cardiol 2007;50:2133-5
  • O'Flaherty M, Ford E, Allender S, et al. Coronary heart disease trends in England and Wales from 1984 to 2004: concealed levelling of mortality rates among young adults. Heart 2008;94:178-81
  • National Center for Health Statistics. Health of the United States, 1990. Hyattsville MD: US Department of Health and Human Services, 1991
  • Herrington DM, Vittinghoff E, Lin F, et al; For the HERS Study Group. Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS). Circulation 2002;105:2962-7
  • Wenger NK, Lewis SJ, Welty FK, et al. TNT Steering Committee and Investigators. Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study. Heart 2008;94:434-9
  • Athyros VG, Kakafika AI, Papageorgiou AA, et al. Effects of statin treatment in men and women with stable coronary heart disease. A subgroup analysis of the GREACE Study. Curr Med Res Opin 2008; in press
  • Athyros VG, Mikhailidis DP, Kakafika AI, et al. Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levels. Curr Drug Targets 2007;8:483-8
  • Athyros VG, Kakafike AI, Papageorgiou AA, et al. Statin-induced increase in HDL-C and renal function in coronary heart disease patients. Open Cardiovasc Med J 2007;1:8-14
  • Athyros VG, Mikhailidis DP, Papageorgiou AA, et al. The effect of statins versus untreated dyslipidemia on renal function in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) study. J Clin Pathol 2004;57:728-34
  • Athyros VG, Mikhailidis DP, Liberopoulos EN, et al. Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study. Nephrol Dial Transplant 2007;22:118-27
  • Athyros VG, Kakafika AI, Papageorgiou AA, et al.; Greace Study Collaborative Group. Atorvastatin decreases triacylglycerol-associated risk of vascular events in coronary heart disease patients. Lipids 2007;42:999-1009
  • Lewis SJ, Sacks FM, Mitchell JS, et al. Effect of pravastatin on cardiovascular events in women after myocardial infarction: the Cholesterol and Recurrent Events (CARE) Trial. J Am Coll Cardiol 1998;32:140-6
  • Miettinen TA, Pyorala K, Olsson AG, et al. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris. Circulation 1997;96:4211-8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.